首页> 外文期刊>Journal of Cancer Research and Therapeutics >Apparent diffusion coefficient value measurements with diffusion magnetic resonance imaging correlated with the expression levels of estrogen and progesterone receptor in breast cancer: A meta-analysis
【24h】

Apparent diffusion coefficient value measurements with diffusion magnetic resonance imaging correlated with the expression levels of estrogen and progesterone receptor in breast cancer: A meta-analysis

机译:弥散磁共振成像与乳腺癌中雌激素和孕激素受体表达水平相关的表观弥散系数值测量:一项荟萃分析

获取原文
       

摘要

Aim: Apparent diffusion coefficient (ADC) value measurement of nodes in diffusion-weighted images (DWI) has been widely used for diagnosis and differential diagnosis of human tumors. We evaluated whether the ADC provided by DWI varies according to the state of estrogen receptors (ER) and progesterone receptors (PR) in breast cancer (BC). Materials and Methods: English and Chinese electronic databases were searched for potentially relevant studies followed by a comprehensive literature search. Summary standardized mean difference (SMD) with 95% confidence interval (CI) was used for ER and PR category of ADC value with the use of the Z test. Results: Final analysis from 6 eligible cohort studies between 2010 and 2012 were selected for inclusion. Overall estimates revealed that the mean ADC of ER-positive or PR-positive cancer was significantly lower than that of ER-negative or PR-negative breast cancer (ER- VS. ER+: SMD = 0.64, 95% CI: 0.02–1.27, P = 0.042; PR- VS. PR+: SMD = 0.45, 95% CI: 0.04–0.86, P = 0.032). Country-stratified analysis indicated the mean ADC of ER-positive cancer was significantly lower in China (SMD = 3.92, 95% CI: 2.22–5.62, P P Conclusion: ADC values vary significantly according to the ER and PR levels in BC patients, indicating that cancer heterogeneity affects imaging parameters. DWI could therefore be critical for clinical applications of ADC values.
机译:目的:弥散加权图像(DWI)中结节的表观弥散系数(ADC)值测量已广泛用于人类肿瘤的诊断和鉴别诊断。我们评估了DWI提供的ADC是否根据乳腺癌(BC)中雌激素受体(ER)和孕激素受体(PR)的状态而变化。材料和方法:检索中英文电子数据库以寻找可能相关的研究,然后进行全面的文献检索。使用Z检验将具有95%置信区间(CI)的汇总标准均值差(SMD)用于ADC值的ER和PR类别。结果:选择了2010年至2012年之间6项合格队列研究的最终分析。总体估算表明,ER阳性或PR阳性乳腺癌的平均ADC显着低于ER阴性或PR阴性乳腺癌的平均ADC(ER- VS. ER +:SMD = 0.64,95%CI:0.02–1.27, P = 0.042; PR-VS。PR +:SMD = 0.45,95%CI:0.04-0.86,P = 0.032)。国家分层分析表明,中国ER阳性癌症的平均ADC显着较低(SMD = 3.92,95%CI:2.22-5.62,PP)结论:根据BC患者的ER和PR水平,ADC值存在显着差异,表明癌症异质性会影响成像参数,因此DWI对于ADC值的临床应用可能至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号